Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| FEDERAL MOGU | FDML | 6.13% |
| RADIANT LOGI | RLGT | 5.32% |
| NATUS MEDICA | BABY | 5.27% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Ciena Corp ( CIEN - Analyst Report ) is scheduled to release its first quarter 2013 results on March 7. Though the company posted a negative surprise of 14.3% in the last quarter, Ciena posted an average surprise of +4.9% over the last four quarters. Let’s see how things are shaping up for the company in this quarter.
Factors Affecting Growth this Past Quarter
Ciena reported dismal fourth-quarter results with the top line failing to meet the Zacks Consensus Estimate. Ciena’s loss per share widened on a year-over-year basis.
The company also reported margin contractions due to unfavorable product mix and higher-than-expected operating expenses.
Ciena expects a tepid first quarter due to reductions in order volume and deployment activity owing to the holiday season. For 2013, management remains optimistic and expects to gain market share, driven by continued spending from telecom carriers that remain focused on upgrading their networks. However, management hinted at subdued gross margins due to start-up costs related to new orders and its deployments.
Earnings Whispers?
The Zacks Consensus Estimate for the first quarter stands at a loss of 25 cents per share while that for fiscal 2013 stands at a loss of 29 cents per share.
There have been no revisions in the first quarter and 2013 estimates over the last 60 days. As a result, the Zacks Consensus Estimate for the two periods remain pinned at 25 cents and 29 cents, respectively.
The lack of downward movement in estimates signals that the first quarter might not be too different from the past quarters. This is also indicated by that fact that the stock carries a Zacks Rank #3 (Hold).
We caution against stocks with Zacks Ranks #4 and #5 (Sell rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.
Other Stocks to Consider
Our model states that a stock needs to have both a positive Zacks Earnings ESP and a Zacks Rank of #1, #2 or #3 to beat earnings estimates. You could, however, consider the following stocks that satisfy both criteria:
Energizer Holdings ( ENR - Analyst Report ) has a Zacks Rank #3 (Hold) and Zacks Earnings ESP of 0.78%.
Fiserv Inc. ( FISV - Analyst Report ) has a Zacks Rank #2 (Buy) and Zacks Earnings ESP of 0.76%.
Akamai Technologies ( AKAM - Analyst Report ) has a Zacks Rank #3 (Hold) and Zacks Earnings ESP of 2.7%.
Read the full reports :
Analyst Report on FISV
Analyst Report on AKAM
Analyst Report on CIEN
Analyst Report on ENR